Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Original Research

Published on 25 Oct 2023

Identification of prognosis-related lncRNAs and cell validation in lung squamous cell carcinoma based on TCGA data

in Cancer Molecular Targets and Therapeutics

Yishuang Cui
Yanan Wu
Mengshi Zhang
Yingze Zhu
Xin Su
Wenyue Kong
Xuan Zheng
Guogui Sun

Frontiers in Oncology

doi 10.3389/fonc.2023.1240868

2,017 views
2 citations

Review

Published on 24 Oct 2023

Lung cancer organoids: models for preclinical research and precision medicine

in Cancer Molecular Targets and Therapeutics

Yajing Liu
Yanbing Zhou
Pu Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1293441

8,987 views
7 citations

Brief Research Report

Published on 18 Oct 2023

Preferences for the sequencing of first-line systemic treatments in metastatic hormone receptor-positive, HER2-negative breast cancer

in Cancer Molecular Targets and Therapeutics

Layal Al Mahmasani
Ghid Amhaz
Reine Abou Zeidane
Nathalie Chamseddine
Taha Hatab
Saad Sabbagh
Maya Charafeddine
Hazem I. Assi

Frontiers in Oncology

doi 10.3389/fonc.2023.1181375

1,399 views
1 citation

Case Report

Published on 18 Oct 2023

Anlotinib combined with pembrolizumab as first-line treatment for advanced pulmonary sarcomatoid carcinoma: a case report and literature review

in Cancer Molecular Targets and Therapeutics

Yingmei Wen
Yi Dong
Lina Yi
Guifang Yang
Mengxia Xiao
Qingqing Li
Chen Zhao
Dafu Ye
Yi Yao

Frontiers in Oncology

doi 10.3389/fonc.2023.1241475

2,109 views
3 citations

Case Report

Published on 18 Oct 2023

Immunohistochemistry combined with NGS to assist the differential diagnosis of multiple primary lung cancer with lymph node metastasis: a case report

in Cancer Molecular Targets and Therapeutics

Chang Liu
Shuai Zhang
Hong Yang
Yu Bai
Yanru Shen
Yi Ren

Frontiers in Oncology

doi 10.3389/fonc.2023.1260759

1,553 views

Review

Published on 16 Oct 2023

Exploring the therapeutic potential of targeting polycomb repressive complex 2 in lung cancer

in Cancer Molecular Targets and Therapeutics

Min Gao
Yongwen Li
Peijun Cao
Hongyu Liu
Jun Chen
Shirong Kang

Frontiers in Oncology

doi 10.3389/fonc.2023.1216289

3,652 views
2 citations

Original Research

Published on 16 Oct 2023

The anti-cancer efficacy of a novel phenothiazine derivative is independent of dopamine and serotonin receptor inhibition

in Cancer Molecular Targets and Therapeutics

Marion Vanneste
Anita Venzke
Soumitra Guin
Andrew J. Fuller
Andrew J. Jezewski
Sarah R. Beattie
Damian J. Krysan
Marvin J. Meyers
Michael D. Henry

Frontiers in Oncology

doi 10.3389/fonc.2023.1295185

2,233 views
2 citations

Original Research

Published on 10 Oct 2023

Survival analysis of patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment of Yunnan in southwestern China: a real-world study

in Cancer Molecular Targets and Therapeutics

Yanping Lin
Long Chen
Rong Li
Xin Liu
Quan Li
Jingjing Cai
Yaxi Du
Guangqiang Zhao
Xiaoxiong Wang
Zhenghai Shen

Frontiers in Oncology

doi 10.3389/fonc.2023.1156647

2,344 views
2 citations

Case Report

Published on 05 Oct 2023

Case Report: Ensartinib for gastric epithelioid inflammatory myofibrosarcoma with STRN-ALK fusion

in Cancer Molecular Targets and Therapeutics

XiaoQing Li
JingFan Zheng
XinYi Li
YuYu Chen
Kang Liu
FangChao Li
Zhong Lu

Frontiers in Oncology

doi 10.3389/fonc.2023.1252221

2,090 views
3 citations

Review

Published on 04 Oct 2023

Use and accuracy of decision support systems using artificial intelligence for tumor diseases: a systematic review and meta-analysis

in Cancer Molecular Targets and Therapeutics

Robert Oehring
Nikitha Ramasetti
Sharlyn Ng
Roland Roller
Philippe Thomas
Axel Winter
Max Maurer
Simon Moosburner
Nathanael Raschzok
Can Kamali

Frontiers in Oncology

doi 10.3389/fonc.2023.1224347

4,549 views
8 citations

Systematic Review

Published on 29 Sep 2023

Arthralgia adverse events due to immune-checkpoint inhibitors for lung cancer patients: a systematic review and meta-analysis

in Cancer Molecular Targets and Therapeutics

Defang Zou
Xiaoping Wang
Yamin Sun
Xi Wang
Chang Lu
Aiyun Wang
Xia Wang
Yan Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1258287

2,553 views
2 citations

Original Research

Published on 29 Sep 2023

Phenotypic heterogeneity drives differential disease outcome in a mouse model of triple negative breast cancer

in Cancer Molecular Targets and Therapeutics

Archana P. Thankamony
Sonny Ramkomuth
Shikha T. Ramesh
Reshma Murali
Priyanka Chakraborty
Nitheesh Karthikeyan
Binitha Anu Varghese
Vishnu Sunil Jaikumar
Mohit Kumar Jolly
Alexander Swarbrick

Frontiers in Oncology

doi 10.3389/fonc.2023.1230647

2,848 views
4 citations

Retraction

Published on 28 Sep 2023

Retraction: AnnexinA5 might suppress the phenotype of human gastric cancer cells via ERK pathway

in Cancer Molecular Targets and Therapeutics

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2023.1294881

1,392 views

Case Report

Published on 27 Sep 2023

Case report: The activity of multi-kinase VEGF inhibitor, Pazopanib, in metastatic undifferentiated round cell sarcomas harboring EWSR1::CREM fusion: clinicopathological series of two cases and literature review

in Cancer Molecular Targets and Therapeutics

Leticia Campoverde
Felipe Camacho
Francesco Alessandrino
Mark G. Evans
Andrew Elliot
Andrew Rosenberg
Jonathan Trent

Frontiers in Oncology

doi 10.3389/fonc.2023.1215003

3,032 views
3 citations

Original Research

Published on 25 Sep 2023

Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model

in Cancer Molecular Targets and Therapeutics

Dalton T. McLean
Jennifer J. Meudt
Loren D. Lopez Rivera
Dominic T. Schomberg
Derek M. Pavelec
Tyler T. Duellman
Darya G. Buehler
Patrick B. Schwartz
Melissa Graham
Laura M. Lee

Frontiers in Oncology

doi 10.3389/fonc.2023.1253659

5,228 views
2 citations

Systematic Review

Published on 25 Sep 2023

The efficacy and safety of different systemic combination therapies on advanced hepatocellular carcinoma: a systematic review and meta-analysis

in Cancer Molecular Targets and Therapeutics

Ping Li
Ming Hu
Mei Liu
Xiangyu Ren
Donghong Liu
Jiluo Liu
Jianhua Yin
Xiaojie Tan
Guangwen Cao

Frontiers in Oncology

doi 10.3389/fonc.2023.1197782

2,210 views
3 citations